LabWalz's profile picture. Advancing peptide-based vaccines for cancer & infectious disease | Translational immunopeptidome studies | T-cell immunology & immunotherapy | @CoE_iFIT member

Peptide-based Immunotherapy

@LabWalz

Advancing peptide-based vaccines for cancer & infectious disease | Translational immunopeptidome studies | T-cell immunology & immunotherapy | @CoE_iFIT member

固定されたツイート

🚨 It's about time to move to the other side 🦋. We will continue posting our latest research on #immunopeptidomics and #clinicaltrials on pbi-tue.bsky.social. See you there! 🚀


Peptide-based Immunotherapy さんがリポスト

We are more than happy that our publication is accepted by @EditorNeuro Fantastic collaboration with @LabWalz academic.oup.com/noa/advance-ar… Check it out ;) @HIHTuebingen @uni_tue_exstra


Peptide-based Immunotherapy さんがリポスト

Thrilled about this symposium @i3S_UPorto featuring influential scientists & word-class research in #immunoengineering: Immunotherapies by Jeff Hubbell, Peptide-based Immunotherapy @LabWalz, Cell Reprogramming in Immunity @CellReproLab, Regenerative Immunotherapies @JHElisseeff!

🚀Join us at the 21st @MOBILIsE_EU Symposium in #MolecularBioengineering" focused on #Immunoengineering! 💡Explore groundbreaking Biomolecular Engineering tools and techniques with leading scientists to advance #immunefunction for #Cancer, #Infection, and #RegenerativeMedicine.

MOBILIsE_EU's tweet image. 🚀Join us at the 21st @MOBILIsE_EU  Symposium in #MolecularBioengineering" focused on #Immunoengineering!
💡Explore groundbreaking Biomolecular Engineering tools and techniques with leading scientists to advance #immunefunction for #Cancer, #Infection, and #RegenerativeMedicine.


Peptide-based Immunotherapy さんがリポスト

New #JITC article: Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression bit.ly/4ejyxSZ @RoerdenM @kevlitchfield @stefanispranger #SITC24

jitcancer's tweet image. New #JITC article: Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression bit.ly/4ejyxSZ @RoerdenM @kevlitchfield @stefanispranger #SITC24

Peptide-based Immunotherapy さんがリポスト

🤔You are a 👩‍🔬 👨‍🔬 #Bioinformatician and have a soft spot for working on mass spectrometry-based #immunopeptidomics and the characterization of #tumor-associated #antigens? 🤗Then become part of @LabWalz and apply now! ➡️jobs.medizin.uni-tuebingen.de/Job/5336/Bioin… #Job #jobopportunities


We are #hiring! 🚀 Join our #bioinformatics team in a truly #interdisciplinary environment driving #immunopeptidomics analyses and pipeline development with direct impact on advancing patient treatment! Check out the full job description: jobs.medizin.uni-tuebingen.de/Job/5336/Bioin…

LabWalz's tweet image. We are #hiring! 🚀 Join our #bioinformatics team in a truly #interdisciplinary environment driving #immunopeptidomics analyses and pipeline development with direct impact on advancing patient treatment! Check out the full job description: jobs.medizin.uni-tuebingen.de/Job/5336/Bioin…

Peptide-based Immunotherapy さんがリポスト

👏Congrats @LabWalz! 🏆Juliane received the SWISS BRIDGE Award 2024! 🇨🇭The prize money of 250,000 Swiss francs supports the implementation of her clinical study investigating new, promising approaches to treating #cancer with #immunotherapies.

CoE_iFIT's tweet image. 👏Congrats @LabWalz! 🏆Juliane received the SWISS BRIDGE Award 2024! 🇨🇭The prize money of  250,000 Swiss francs supports the implementation of her clinical  study investigating new, promising approaches to treating #cancer with  #immunotherapies.

Congratulations to Susanne Jung on winning the poster #award at this year's #DGHO24 meeting in #Basel. She was introducing our #clinicaltrial using #peptide-based #vaccination for the treatment of #fibrolamellar #hcc #patients. @dgho_eV

LabWalz's tweet image. Congratulations to Susanne Jung on winning the poster #award at this year's #DGHO24 meeting in #Basel. She was introducing our #clinicaltrial using #peptide-based #vaccination for the treatment of #fibrolamellar #hcc #patients.
@dgho_eV

Proud to announce that @JulianeWalz received the Robert Pfleger Foundation #research #award for peptide-based #immunotherapy of #tumors and #infections! Congrats also to Marion @subklewe for her award! 🚀

LabWalz's tweet image. Proud to announce that @JulianeWalz received the Robert Pfleger Foundation #research #award for peptide-based #immunotherapy of #tumors and #infections! Congrats also to Marion @subklewe for her award! 🚀

Peptide-based Immunotherapy さんがリポスト

🥳#Congrats to our spokesperson @JulianeWalz! 🏆 She received the #Research #Award from the Robert Pfleger Foundation! The #prize is endowed with 50,000€ and is awarded every two years. The Foundation honors the achievements of Prof. Walz regarding peptid-based #immunotherapy

CoE_iFIT's tweet image. 🥳#Congrats to our spokesperson @JulianeWalz! 🏆 She received the #Research #Award from the Robert Pfleger Foundation! The #prize is endowed with 50,000€ and is awarded every two years. The Foundation honors the achievements of Prof. Walz regarding peptid-based #immunotherapy

Today we had the honor to welcome Marna Davis the founder of the #fibrolammelar #carcinoma @FibroFoundation. She brought us a big surprise: The #approval of our grant to fund a #clinicalstudy with our fusion-based peptide vaccine in FLC #patients.

LabWalz's tweet image. Today we had the honor to welcome Marna Davis the founder of the #fibrolammelar #carcinoma @FibroFoundation. She brought us a big surprise: The #approval of our grant to fund a #clinicalstudy with our fusion-based peptide vaccine in FLC #patients.

Great talks at the 6th ForTra Workshop for Translational Research.@EKFZdigital

LabWalz's tweet image. Great talks at the 6th ForTra Workshop for Translational Research.@EKFZdigital

Peptide-based Immunotherapy さんがリポスト

😃Happy to share the next episode of @uni_tue & @uni_tue_exstra🎙️ #podcast "Key to My Research" with iFIT participation! In this episode @LabWalz explains the benefits of peptid-based #immunotherapy and how #cancer peptide #vaccines work! 🎧Tune in: keytomyresearch.podbean.com/e/deep-dive-ca…


Peptide-based Immunotherapy さんがリポスト

👀#SneakPeek! @JulianeWalz had a great time during today's "meeting" with host Jennifer Raffler! We cannot reveal much, but keep an eye on the social media channels of @uni_tue next week! 🎙️🎧 #cancerresearch #immunotherapy #cancervaccine

CoE_iFIT's tweet image. 👀#SneakPeek! @JulianeWalz had a great time during today's "meeting" with host Jennifer Raffler! We cannot reveal much, but keep an eye on the social media channels of @uni_tue next week! 🎙️🎧
#cancerresearch #immunotherapy #cancervaccine

Another great white party in the heart of #Tübingen together with @Salihlab! 🥂 We officially announce the ennoblement of the Lady and Lord of the Glen!

LabWalz's tweet image. Another great white party in the heart of #Tübingen together with @Salihlab! 🥂 We officially announce the ennoblement of the Lady and Lord of the Glen!
LabWalz's tweet image. Another great white party in the heart of #Tübingen together with @Salihlab! 🥂 We officially announce the ennoblement of the Lady and Lord of the Glen!
LabWalz's tweet image. Another great white party in the heart of #Tübingen together with @Salihlab! 🥂 We officially announce the ennoblement of the Lady and Lord of the Glen!
LabWalz's tweet image. Another great white party in the heart of #Tübingen together with @Salihlab! 🥂 We officially announce the ennoblement of the Lady and Lord of the Glen!

Peptide-based Immunotherapy さんがリポスト

Just a quick reminder for today's lecture within @uni_tue #summer #university! Join @BettinaWeigelin on her fascinating journey into the world of #cancer #immunotherapies!

You got plans for your #summer #vacation? What about visiting the @uni_tue summer #university? Join @BettinaWeigelin on a great #lecture with the title "Invisible heroes: #Microscopic insights into #cancer #immunotherapies" 🗓️August 5 🕐10:15am 🏢Liebermeisterstraße 16

CoE_iFIT's tweet image. You got plans for your #summer #vacation? What about visiting the @uni_tue summer #university? Join @BettinaWeigelin on a great #lecture with the title "Invisible heroes: #Microscopic insights into #cancer #immunotherapies" 
🗓️August 5
🕐10:15am
🏢Liebermeisterstraße 16


Congratulations to @YMaringer and @JonasRieth for successfully defending their #PhD thesis! What a great journey we had and still have with you!🥂

LabWalz's tweet image. Congratulations to @YMaringer and @JonasRieth for successfully defending their #PhD thesis! What a great journey we had and still have with you!🥂
LabWalz's tweet image. Congratulations to @YMaringer and @JonasRieth for successfully defending their #PhD thesis! What a great journey we had and still have with you!🥂
LabWalz's tweet image. Congratulations to @YMaringer and @JonasRieth for successfully defending their #PhD thesis! What a great journey we had and still have with you!🥂
LabWalz's tweet image. Congratulations to @YMaringer and @JonasRieth for successfully defending their #PhD thesis! What a great journey we had and still have with you!🥂

Thanks to @bruker for organizing a great local event in #Tübingen! Naomi gave a great talk about #peptide based #Immunotherapy! Further impressions: linkedin.com/messaging/thre…

LabWalz's tweet image. Thanks to @bruker for organizing a great local event in #Tübingen! Naomi gave a great talk about #peptide based #Immunotherapy!
Further impressions: linkedin.com/messaging/thre…

Peptide-based Immunotherapy さんがリポスト

👏#Congrats to our iFIT 2024 class who succesfully mastered the "Excellence in International #STEM #Communication, Productivity and #Career Skills" program by coach Dr. Paul Charlton! Equipped with the skillset to face the challenges of their future scientific careers!

CoE_iFIT's tweet image. 👏#Congrats to our iFIT 2024 class who succesfully mastered the "Excellence in International #STEM #Communication, Productivity and #Career Skills" program by coach Dr. Paul Charlton! Equipped with the skillset to face the challenges of their future scientific careers!

Loading...

Something went wrong.


Something went wrong.